Krystal Biotech Announces Initiation of Phase 1/2 Study of KB105 in Transglutaminase-1 (“TGM1”) Deficient Autosomal Recessive Congenital Ichthyosis (“ARCI”) September 4, 2019 - NASDAQ Companies 0 » View More News for September 04, 2019